GMAB

Genmab A/SC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

GMAB vs peer average

46/100

GMAB vs. peer average (C vs. C)

Grade spread

B 5 · C 2 · D 1 · F 1

Graded peers loaded

Coverage

9 graded

100% of tracked

Peer overview

ASND is the first available peer comparator.

Similar-sized same-sector biopharma reference; useful for relative scale, but not a like-for-like comparison with Genmab’s oncology and royalty exposure.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerASNDAscendis A/S

GMAB

Genmab A/S

ASND

Ascendis A/S

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Mixed

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs ASND

GMAB / ASND

Grade Position

In line

GMAB vs. peer average (C vs. C)

46/100

Momentum

GMAB

Value

GMAB

Sentiment

GMAB

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs GMAB

ASND

20/100

JAZZ

80/100

-1

GILD

80/100

-1

VTRS

Viatris Inc Common

60/100

Even

UTHR

United Therapeutics Corp Common

80/100

-1

ASND is the first peer returned for this comparison set.